IL184008A - 4-cycloalkyl-substituted tetrahydroquinoline derivatives and use thereof as medicaments - Google Patents

4-cycloalkyl-substituted tetrahydroquinoline derivatives and use thereof as medicaments

Info

Publication number
IL184008A
IL184008A IL184008A IL18400807A IL184008A IL 184008 A IL184008 A IL 184008A IL 184008 A IL184008 A IL 184008A IL 18400807 A IL18400807 A IL 18400807A IL 184008 A IL184008 A IL 184008A
Authority
IL
Israel
Prior art keywords
compound
formula
inhibitors
salts
solvates
Prior art date
Application number
IL184008A
Other languages
English (en)
Other versions
IL184008A0 (en
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004061000A external-priority patent/DE102004061000A1/de
Priority claimed from DE102004060997A external-priority patent/DE102004060997A1/de
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IL184008A0 publication Critical patent/IL184008A0/en
Publication of IL184008A publication Critical patent/IL184008A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL184008A 2004-12-18 2007-06-18 4-cycloalkyl-substituted tetrahydroquinoline derivatives and use thereof as medicaments IL184008A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004061000A DE102004061000A1 (de) 2004-12-18 2004-12-18 Chemische Verbindung und ihre Verwendung
DE102004060997A DE102004060997A1 (de) 2004-12-18 2004-12-18 Chemische Verbindung und ihre Verwendung
PCT/EP2005/013490 WO2006063828A1 (de) 2004-12-18 2005-12-15 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente

Publications (2)

Publication Number Publication Date
IL184008A0 IL184008A0 (en) 2007-10-31
IL184008A true IL184008A (en) 2012-03-29

Family

ID=35841894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184008A IL184008A (en) 2004-12-18 2007-06-18 4-cycloalkyl-substituted tetrahydroquinoline derivatives and use thereof as medicaments

Country Status (27)

Country Link
US (2) US8124775B2 (https=)
EP (1) EP1828137B1 (https=)
JP (1) JP5132317B2 (https=)
KR (1) KR20070090248A (https=)
AR (1) AR055011A1 (https=)
AT (1) ATE555097T1 (https=)
AU (1) AU2005315770B2 (https=)
BR (1) BRPI0519602A2 (https=)
CA (1) CA2591397A1 (https=)
CU (1) CU23452B7 (https=)
CY (1) CY1112887T1 (https=)
DK (1) DK1828137T3 (https=)
DO (1) DOP2005000259A (https=)
ES (1) ES2384980T3 (https=)
GT (1) GT200500377A (https=)
IL (1) IL184008A (https=)
MA (1) MA29100B1 (https=)
MX (1) MX2007007188A (https=)
NO (1) NO20073146L (https=)
PE (1) PE20060767A1 (https=)
PL (1) PL1828137T3 (https=)
PT (1) PT1828137E (https=)
RU (1) RU2393151C2 (https=)
SI (1) SI1828137T1 (https=)
TW (1) TW200635900A (https=)
UY (1) UY29276A1 (https=)
WO (1) WO2006063828A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005324127A1 (en) * 2004-12-18 2006-07-13 Bayer Healthcare Ag (5S) -3-[(S)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as CETP inhibitors
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
DK2268644T3 (da) * 2008-03-05 2011-10-10 Boehringer Ingelheim Int Tricycliske pyridinderivater, medikamenter indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde til deres fremstilling
EA201201160A1 (ru) 2010-02-19 2013-04-30 Бёрингер Ингельхайм Интернациональ Гмбх Трициклические производные пиридина, лекарственные средства, содержащие такие соединения, их применение и способ их получения
AU2011274903B2 (en) * 2010-07-09 2016-09-08 Daiichi Sankyo Company, Limited Substituted pyridine compound
WO2012110599A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim International Gmbh Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
JP5947382B2 (ja) 2011-08-17 2016-07-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング フロ［３，４−ｃ］キノリン誘導体、このような化合物を含む薬物、それらの使用及びそれらの調製方法
ES2599757T3 (es) 2012-01-06 2017-02-03 Daiichi Sankyo Company, Limited Sales de aducto de ácido de un compuesto de piridina sustituido como inhibidores de la proteína de transferencia de ésteres de colesterilo (PTEC)
RU2703192C2 (ru) 2014-07-30 2019-10-15 Ф. Хоффманн-Ля Рош Аг Генетические маркеры для прогнозирования ответа на терапию поднимающими уровень hdl или имитирующими hdl агентами
WO2025185022A1 (zh) * 2024-03-05 2025-09-12 维康平生(北京)生物科技有限公司 一种脂肪体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4128681A1 (de) * 1991-08-29 1993-03-04 Bayer Ag Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE19610932A1 (de) * 1996-03-20 1997-09-25 Bayer Ag 2-Aryl-substituierte Pyridine
DE19627430A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Bicyclisch kondensierte Pyridine
HRP970330B1 (en) 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
DE19627431A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
US6207671B1 (en) * 1996-07-08 2001-03-27 Bayer Aktiengesellschaft Cycloalkano-pyridines
DE19704244A1 (de) * 1997-02-05 1998-08-06 Bayer Ag 5-Hydroxy-alkyl substituierte Phenyle
DE19709125A1 (de) 1997-03-06 1998-09-10 Bayer Ag Substituierte Chinoline
MA24643A1 (fr) 1997-09-18 1999-04-01 Bayer Ag Tetrahydro-naphtalenes substitues et composes analogues
DE19741051A1 (de) * 1997-09-18 1999-03-25 Bayer Ag Hetero-Tetrahydrochinoline
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline
DE19935966A1 (de) 1999-07-30 2001-02-01 Bayer Ag Verfahren zur Reduktion von Ketoalkoholen
DE10148436A1 (de) * 2001-10-01 2003-04-17 Bayer Ag Tetrahydrochinoline
DE10250687A1 (de) * 2002-10-31 2004-05-13 Bayer Ag 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung
AU2005324127A1 (en) * 2004-12-18 2006-07-13 Bayer Healthcare Ag (5S) -3-[(S)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as CETP inhibitors

Also Published As

Publication number Publication date
CU23452B7 (es) 2009-12-01
KR20070090248A (ko) 2007-09-05
CY1112887T1 (el) 2016-04-13
AR055011A1 (es) 2007-08-01
RU2393151C2 (ru) 2010-06-27
AU2005315770B2 (en) 2011-12-08
BRPI0519602A2 (pt) 2009-02-25
PT1828137E (pt) 2012-07-04
JP2008524145A (ja) 2008-07-10
DK1828137T3 (da) 2012-07-23
CA2591397A1 (en) 2006-06-22
AU2005315770A1 (en) 2006-06-22
ATE555097T1 (de) 2012-05-15
TW200635900A (en) 2006-10-16
US20080255068A1 (en) 2008-10-16
PL1828137T3 (pl) 2012-09-28
RU2007127127A (ru) 2009-01-27
WO2006063828A1 (de) 2006-06-22
US20120142728A1 (en) 2012-06-07
IL184008A0 (en) 2007-10-31
MA29100B1 (fr) 2007-12-03
EP1828137B1 (de) 2012-04-25
GT200500377A (es) 2006-11-09
PE20060767A1 (es) 2006-09-10
EP1828137A1 (de) 2007-09-05
ES2384980T3 (es) 2012-07-16
SI1828137T1 (sl) 2012-08-31
MX2007007188A (es) 2007-08-14
JP5132317B2 (ja) 2013-01-30
UY29276A1 (es) 2006-07-31
US8124775B2 (en) 2012-02-28
DOP2005000259A (es) 2006-11-15
NO20073146L (no) 2007-09-18

Similar Documents

Publication Publication Date Title
US20120142728A1 (en) Chemical compound and its use
US20080194609A1 (en) Chemical Compound and Its Use
EP3893889B1 (en) Thrb receptor agonist compound and preparation method and use thereof
US8227511B2 (en) Substituted chromanol derivatives and their use
US10759721B2 (en) Deuterated CFTR potentiators
CZ214497A3 (cs) Heterocyklicky kondensované pyridiny, způsob jejich výroby, farmaceutické prostředky tyto látky obsahující a jejich použití
EP2318410A2 (en) New small-molecule pde-10 inhibitors
JP2008524255A (ja) 化学物質
CA2819106C (en) Kat ii inhibitors
CN101124206B (zh) 4-环烷基取代的四氢喹啉衍生物及其作为药物的用途
HK1117832A (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
DE102004061001A1 (de) Chemische Verbindung und ihre Verwendung
KR100470192B1 (ko) 안드로겐수용체변조제화합물및방법
DE102004061002A1 (de) Chemische Verbindung und ihre Verwendung
DE102004061000A1 (de) Chemische Verbindung und ihre Verwendung
HK40127942A (en) Thrb receptor agonist compound and preparation method and use thereof
DE102004060998A1 (de) Chemische Verbindung und ihre Verwendung
DE102004061003A1 (de) Chemische Verbindung und ihre Verwendung

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees